Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biorunon Jan 21, 2023 10:59am
190 Views
Post# 35237299

RE:RE:RE:RE:RE:Friday Knee Slapper

RE:RE:RE:RE:RE:Friday Knee SlapperYou remember that the pp at 40 was in and around the time tinyi letter was signed right, which is chinese interest, no? 

biofool, we are all pissed off right now at the share price and you are focusing in the wrong direction. go talk to whoever at prc if you want to work through your issues, but don't call me, who is a hard working and honest Canadian, a criminal or a manipulator. 

go on the chart and slide over your mouse and you will see that the last time we were at this price was around the end of january 2023. so here we are again..

I don't know about you but there was a lot of hope and excitement since then, and this was because there were good things happening at Sirona. And then time goes on and we alk realize their growing pains and gaps. Not the same company though as their science pipelines have evolved considerably, clinical partnerships abound, and now there is a global license with one of the top pharmaceuticals.




<< Previous
Bullboard Posts
Next >>